Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
XBiotech Inc. (XBIT) had Normalized Income after Taxes of $-6.73M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-6.73M |
|
-- |
|
-- |
|
$6.15M |
|
$-6.15M |
|
$-0.54M |
|
$-6.68M |
|
$-6.68M |
|
$-6.73M |
|
$-6.73M |
|
$-6.73M |
|
|
Normalized Income after Taxes |
$-6.73M |
$-6.15M |
|
$-5.84M |
|
30.49M |
|
30.49M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$111.16M |
|
$22.49M |
|
$22.49M |
|
$133.65M |
|
$3.35M |
|
-- |
|
$1.84M |
|
$5.19M |
|
$128.46M |
|
$128.46M |
|
$128.46M |
|
30.49M |
|
| Cash Flow Statement Financials | |
$-13.48M |
|
$0.01M |
|
-- |
|
$125.55M |
|
$109.53M |
|
$-16.02M |
|
$0.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
33.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.48M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.24% |
|
-5.24% |
|
-5.03% |
|
-5.24% |
|
$4.21 |
|
$-0.44 |
|
$-0.44 |
|